Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 205
Consulting Firm McKinsey to Pay $650 Million to Resolve Feds’ Opioid Investigation
OPLA Bars Opioid-Related Public Nuisance Claims Against Pharmacies, Ohio High Court Rules